Interactive Effects of Ovarian Steroid Hormones on Alcohol Use and Binge Drinking Across the Menstrual Cycle

Patterns and features of substance use and abuse vary across the menstrual cycle in humans. Yet, little work has systematically examined the within-person relationships between ovarian hormone changes and alcohol use across the menstrual cycle. Our study was the first to examine the roles of within-person levels of estradiol (E2) and progesterone (P4) in relation to daily alcohol use and binge drinking in young women. Participants were 22 naturally cycling women, ages 18-22, recruited through a university subject pool who reported any alcohol use and who completed a screening visit assessing study eligibility, followed by 35 subsequent days of data collection. E2 and P4 were obtained via enzyme immunoassay of saliva samples collected by participants each morning, 30 min after waking. Presence and degree of daily substance use were obtained using an adaptation of the Timeline FollowBack Interview completed daily. Results indicated that elevated E2 in the context of decreased P4 levels were associated with higher risk of drinking and binge drinking. These effects were present only on weekend days. Results are suggestive of a dual risk model in which both ovulatory E2 increases and perimenstrual P4 decreases increase risk for drinking. Differential associations of steroids with drinking across the menstrual cycle may suggest the need for clinical assessment of substance use to take into account hormone dynamics and menstrual cycle phase

A Network Analysis of Developmental Change in ADHD Symptom Structure from Preschool to Adulthood

Although there is substantial support for the validity of the diagnosis of attention-deficit/hyperactivity disorder (ADHD), there is considerable disagreement about how to best capture developmental changes in the expression of ADHD symptomatology. This article examines the associations among the 18 individual ADHD symptoms using a novel network analysis approach, from preschool to adulthood. The 1,420 participants were grouped into four age brackets: preschool (ages 3–6, n = 109), childhood (ages 6–12, n = 548), adolescence (ages 13–17, n = 357), and young adulthood (ages 18–36, n = 406). All participants completed a multistage, multi-informant diagnostic process, and self and informant symptom ratings were obtained. Network analysis indicated ADHD symptom structure became more differentiated over development. Two symptoms, often easily distracted and difficulty sustaining attention, appeared as central, or core, symptoms across all age groups. Thus, a small number of core symptoms may warrant extra weighting in future diagnostic systems

Psychophysiological models of hypovigilance detection: A scoping review

Hypovigilance represents a major contributor to accidents. In operational contexts, the burden of monitoring/managing vigilance often rests on operators. Recent advances in sensing technologies allow for the development of psychophysiology‐based (hypo)vigilance prediction models. Still, these models remain scarcely applied to operational situations and need better understanding. The current scoping review provides a state of knowledge regarding psychophysiological models of hypovigilance detection. Records evaluating vigilance measuring tools with gold standard comparisons and hypovigilance prediction performances were extracted from MEDLINE, PsychInfo, and Inspec. Exclusion criteria comprised aspects related to language, non‐empirical papers, and sleep studies. The Quality Assessment tool for Diagnostic Accuracy Studies (QUADAS) and the Prediction model Risk Of Bias ASsessment Tool (PROBAST) were used for bias evaluation. Twenty‐one records were reviewed. They were mainly characterized by participant selection and analysis biases. Papers predominantly focused on driving and employed several common psychophysiological techniques. Yet, prediction methods and gold standards varied widely. Overall, we outline the main strategies used to assess hypovigilance, their principal limitations, and we discuss applications of these models

Mathematical modelling of cytokines, MMPs and fibronectin fragments in osteoarthritic cartilage

Osteoarthritis (OA) is a degenerative disease which causes pain and stiffness in joints. OA progresses through excessive degradation of joint cartilage, eventually leading to significant joint degeneration and loss of function. Cytokines, a group of cell signalling proteins, present in raised concentrations in OA joints, can be classified into pro-inflammatory and anti-inflammatory groups. They mediate cartilage degradation through several mechanisms, primarily the up-regulation of matrix metalloproteinases (MMPs), a group of collagen-degrading enzymes. In this paper we show that the interactions of cytokines within cartilage have a crucial role to play in OA progression and treatment. We develop a four-variable ordinary differential equation model for the interactions between pro- and anti-inflammatory cytokines, MMPs and fibronectin fragments (Fn-fs), a by-product of cartilage degradation and upregulator of cytokines. We show that the model has four classes of dynamic behaviour: homoeostasis, bistable inflammation, tristable inflammation and persistent inflammation. We show that positive and negative feedbacks controlling cytokine production rates can determine either a pre-disposition to OA or initiation of OA. Further, we show that manipulation of cytokine, MMP and Fn-fs levels can be used to treat OA, but we suggest that multiple treatment targets may be essential to halt or slow disease progression

Temperament Pathways to Childhood Disruptive Behavior and Adolescent Substance Abuse: Testing a Cascade Model

Abstract Temperament traits may increase risk for developmental psychopathology like Attention-Deficit/Hyperactivity Disorder (ADHD) and disruptive behaviors during childhood, as well as predisposing to substance abuse during adolescence. In the current study, a cascade model of trait pathways to adolescent substance abuse was examined. Component hypotheses were that (a) maladaptive traits would increase risk for inattention/hyperactivity, (b) inattention/hyperactivity would increase risk for disruptive behaviors, and (c) disruptive behaviors would lead to adolescent substance abuse. Participants were 674 children (486 boys) from 321 families in an ongoing, longitudinal high risk study that began when children were 3 years old. Temperament traits assessed were reactive control, resiliency, and negative emotionality, using examiner ratings on the California Q-Sort. Parent, teacher, and self ratings of inattention/hyperactivity, disruptive behaviors, and substance abuse were also obtained. Low levels of childhood reactive control, but not resiliency or negative emotionality, were associated with adolescent substance abuse, mediated by disruptive behaviors. Using a cascade model, family risk for substance abuse was partially mediated by reactive control, inattention/hyperactivity, and disruptive behavior. Some, but not all, temperament traits in childhood were related to adolescent substance abuse; these effects were mediated via inattentive/hyperactive and disruptive behaviors.This work was supported by NIAAA grant R01-AA12217 to Robert Zucker and Joel Nigg, NIAAA grant R37-AA07065 to Robert Zucker and Hiram Fitzgerald, and NIMH grant R01-MH59105 to Joel Nigg. Martel was supported by 1 F31 MH075533-01A2.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/64507/1/#167, Martel 2009, Temperament path to disruptive behav and sub abuse JACP.pd

Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study

Background: The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on postoperative recovery needs to be understood to inform clinical decision making during and after the COVID-19 pandemic. This study reports 30-day mortality and pulmonary complication rates in patients with perioperative SARS-CoV-2 infection. Methods: This international, multicentre, cohort study at 235 hospitals in 24 countries included all patients undergoing surgery who had SARS-CoV-2 infection confirmed within 7 days before or 30 days after surgery. The primary outcome measure was 30-day postoperative mortality and was assessed in all enrolled patients. The main secondary outcome measure was pulmonary complications, defined as pneumonia, acute respiratory distress syndrome, or unexpected postoperative ventilation. Findings: This analysis includes 1128 patients who had surgery between Jan 1 and March 31, 2020, of whom 835 (74·0%) had emergency surgery and 280 (24·8%) had elective surgery. SARS-CoV-2 infection was confirmed preoperatively in 294 (26·1%) patients. 30-day mortality was 23·8% (268 of 1128). Pulmonary complications occurred in 577 (51·2%) of 1128 patients; 30-day mortality in these patients was 38·0% (219 of 577), accounting for 81·7% (219 of 268) of all deaths. In adjusted analyses, 30-day mortality was associated with male sex (odds ratio 1·75 [95% CI 1·28–2·40], p\textless0·0001), age 70 years or older versus younger than 70 years (2·30 [1·65–3·22], p\textless0·0001), American Society of Anesthesiologists grades 3–5 versus grades 1–2 (2·35 [1·57–3·53], p\textless0·0001), malignant versus benign or obstetric diagnosis (1·55 [1·01–2·39], p=0·046), emergency versus elective surgery (1·67 [1·06–2·63], p=0·026), and major versus minor surgery (1·52 [1·01–2·31], p=0·047). Interpretation: Postoperative pulmonary complications occur in half of patients with perioperative SARS-CoV-2 infection and are associated with high mortality. Thresholds for surgery during the COVID-19 pandemic should be higher than during normal practice, particularly in men aged 70 years and older. Consideration should be given for postponing non-urgent procedures and promoting non-operative treatment to delay or avoid the need for surgery. Funding: National Institute for Health Research (NIHR), Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, NIHR Academy, Sarcoma UK, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research

The Science Performance of JWST as Characterized in Commissioning

This paper characterizes the actual science performance of the James Webb Space Telescope (JWST), as determined from the six month commissioning period. We summarize the performance of the spacecraft, telescope, science instruments, and ground system, with an emphasis on differences from pre-launch expectations. Commissioning has made clear that JWST is fully capable of achieving the discoveries for which it was built. Moreover, almost across the board, the science performance of JWST is better than expected; in most cases, JWST will go deeper faster than expected. The telescope and instrument suite have demonstrated the sensitivity, stability, image quality, and spectral range that are necessary to transform our understanding of the cosmos through observations spanning from near-earth asteroids to the most distant galaxies.Comment: 5th version as accepted to PASP; 31 pages, 18 figures; https://iopscience.iop.org/article/10.1088/1538-3873/acb29

Developmental pathways to disruptive, impulse-control, and conduct disorders /

Developmental Pathways to Disruptive, Impulse-Control, and Conduct Disorders provides essential understanding on how disruptive behavior disorder (DBD) is characterized, its early markers and etiology, and the empirically-based treatment for the disorder. The book covers features and assessment of various DBDs, including oppositional-defiant disorder, conduct disorder, and antisocial personality disorder, the psychological markers of externalizing problems, such as irritability and anger, common elements of effective evidence-based treatments for DBD for behavioral treatments, cognitive therapies, and family and community therapies. A final section discusses new and emerging insights in the prevention and treatment of DBD.Front Cover; Developmental Pathways to Disruptive, Impulse-Control, and Conduct Disorders; Copyright Page; Dedication; Contents; List of Contributors; I. Features and Assessment of Disruptive, Impulse-Control, and Conduct Disorders; 1 Disruptive, impulse-control, and conduct disorders; Introduction; Key issues in classifying disruptive behavior disorders; A brief history of classifying disruptive behavior disorders; Oppositional defiant disorder; Conduct disorder; Antisocial personality disorder; Intermittent explosive disorder; Pyromania and kleptomania.The international classification of diseasesSummary; References; Further Reading; 2 Oppositional defiant disorder; A brief history of ODD; Prevalence rates; Gender differences in prevalence rates; Onset and persistence; A dimensional model of ODD; Chronic irritability; What does temper loss indicate?; How distinct are the ODD dimensions?; ODD dimensions and Disruptive Mood Dysregulation Disorder; Dimensions of ODD and the comorbidity of ODD with other psychopathology; Clinical utility of the dimensional model; Related dimensions; Risk factors; Genetics; ODD, temperament, and personality.Parenting and family contextParental hostility; Coercive parent-child interactions; ODD in the school context; ODD and clinical issues; Informant effects; Assessment tools; Treatment; Conclusions; References; Further Reading; 3 Conduct disorder: a neurodevelopmental perspective; Historical context; Prevalence and overview of societal costs; Sex differences; Etiology as a multifactorial ontogenic process; Genetic vulnerabilities; Behavioral genetics; Molecular genetics; Linkage studies; Association studies; Genome-wide association studies; Structural variants; Epigenetics.Neural vulnerabilitiesSubcortical emotion generation mechanisms; Cortical emotion regulation mechanisms; Hormonal vulnerabilities; Testosterone; Cortisol; Cognitive vulnerabilities; Environmental risk mediators; Poverty/SES; Family risk; Peer and neighborhood risk factors; Diagnosis and assessment; Diagnostic and Statistical Manual of Mental Disorders; Empirically based taxonomies; Prevention/intervention; Prevention; Intervention; Childhood; Adolescence; Iatrogenesis; Neurobiological mechanisms; Conclusions and future directions; Funding; References; Further Reading.4 Antisocial-psychopathic personality disorderAlternative conceptualizations of ASPD and psychopathy; DSM-5 ASPD/psychopathy; The quandary of fearlessness and boldness; Characteristics of psychopathy from the perspective of the FFM; Psychopathy as conceptualized by Cleckley; Fearlessness and boldness as adaptive personality strengths; Successful psychopathy; Forensic assessment; Comorbidity; Narcissistic personality disorder; Substance use disorders; Criminal behavior; Etiology; Underlying pathology; Course; Treatment; Conclusions; References; II. Risk Markers of Externalizing Problems.Online resource; title from PDF title page (EBSCO, viewed June 26, 2018)Includes bibliographical references and index.Developmental Pathways to Disruptive, Impulse-Control, and Conduct Disorders provides essential understanding on how disruptive behavior disorder (DBD) is characterized, its early markers and etiology, and the empirically-based treatment for the disorder. The book covers features and assessment of various DBDs, including oppositional-defiant disorder, conduct disorder, and antisocial personality disorder, the psychological markers of externalizing problems, such as irritability and anger, common elements of effective evidence-based treatments for DBD for behavioral treatments, cognitive therapies, and family and community therapies. A final section discusses new and emerging insights in the prevention and treatment of DBD.Elsevie